CD44 and squamous cell carcinoma: Tongue squamous cell carcinoma cell lines treated with RSPO2 have higher numbers of the CD44+, CD133+, and ALDH+ CSC population, possess a high expression of CSC markers (CD133, OCT4, SOX2, and CD44), and exhibit increased sphere formation ability [115].